Histoplasmosis
Clinical trials for Histoplasmosis explained in plain language.
Never miss a new study
Get alerted when new Histoplasmosis trials appear
Sign up with your email to follow new studies for Histoplasmosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo could shorten histoplasmosis treatment by half
Disease control Not yet recruitingThis study tests if a single high dose of an antifungal drug works better than the standard daily dose for treating moderate to severe histoplasmosis, a serious lung infection. It also compares a newer oral drug to the standard one, and checks if 6 months of treatment is as good …
Matched conditions: HISTOPLASMOSIS
Phase 3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a new pill tame fungal infections when standard drugs fail?
Disease control Not yet recruitingThis Phase 2 trial tests an oral antifungal drug called oteseconazole in adults with dimorphic fungal infections, including coccidioidomycosis, blastomycosis, and histoplasmosis. Participants must already be on antifungal therapy but need a different option because standard first…
Matched conditions: HISTOPLASMOSIS
Phase 2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Prison walls may not stop Animal-Borne diseases
Knowledge-focused Not yet recruitingResearchers are measuring how often five animal-borne infections appear among inmates at the French Guiana Correctional Facility. The study follows newly arrived adults for up to 12 months, testing for Q fever, leptospirosis, Chagas disease, histoplasmosis, and toxoplasmosis. The…
Matched conditions: HISTOPLASMOSIS
Sponsor: Centre Hospitalier de Cayenne • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC